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Abstract 
A 56 year-old male presented with symptoms of pneumonia and findings consistent with 
acute lung injury (ALI). Deterioration of respiratory function occurred over the first 24 hours of 
hospitalization leading to placement in an intensive care unit (ICU) followed by tracheal intubation 
and  mechanical ventilation (ETMV).  At that time criteria defining acute respiratory distress 
syndrome (ARDS) were present.   The palliative medicine service was asked to address concerns 
expressed by the patient’s spouse reflecting uncertainty regarding outcome expectations.   
When interacting with families of incapacitated critically ill patients, clinicians are advised 
to employ a patient-centered communication process to alleviate family distress and facilitate 
making necessary decisions in a shared manner.  Acknowledging and confronting the 
uncertainties of a critical illness is an essential component of patient-centered communication.  
Addressing and managing uncertainty for this case scenario requires consideration of both short- 
and long-term outcomes including mortality, ventilator independence, and adverse effects on 
quality of life for survivors. In this paper, ALI/ARDS requiring ETMV in the ICU was used as a 
focal point for preparing a prognostic assessment incorporating these issues.  This assessment 
was based on a review of recently published literature regarding mortality and ventilator 
independence of survivors for adult patients receiving ETMV for ALI/ARDS in the ICU.  In 
the studies reviewed, long-term survival reported at 60 days to 1 year was 50-73% with 
greater than 84% of the survivors in each study breathing independently. Selected articles 
discussing outcomes other than mortality or recovery of respiratory function, particularly quality of 
life implications for ALI/ARDS survivors, were also reviewed.  
 This case example of ALI/ARDS requiring ETMV in the ICU is used to illustrate the 
situation of an incapacitated critically ill patient where the outcome is uncertain.  Patient-centered 
communication with the patient’s representative should acknowledge and address this 
uncertainty.  Managing uncertainty consists of effectively expressing a carefully formulated 
prognostic assessment and using sound communication principles to alleviate the distress 
associated with the uncertain outcome probabilities.   
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Case Scenario 
 A 56 year old male without prior respiratory disease presented with fever, cough, and 
dyspnea resulting in hospitalization for severe community-acquired pneumonia.  Oximeter 
readings and subjective shortness of breath worsened during the first 24 hours after admission 
despite increasing levels of oxygen administered by face mask.  On the second day of 
hospitalization continued clinical evidence of increased work of breathing and poor O2 saturation 
readings despite a maximal rebreather O2 mask necessitated transfer to the intensive care unit, 
tracheal intubation, and initiation of mechanical ventilator support. Continuous intravenous 
sedation was implemented.  Initial ventilator settings were volume assist control with a tidal 
volume of 6 ml/kg, FiO2 0.6 (60%), and positive end expiratory pressure of 10 cm H2O.  Arterial 
blood gases revealed a PaO2 of 60 mm Hg (PaO2/FiO2 = 100). Extensive bilateral alveolar 
infiltrates were seen on chest X-ray. No clinical or echocardiographic evidence of cardiac 
dysfunction was detected. 
 During intensive care unit rounds on the third hospital day the patient’s spouse was 
informed of the clinical diagnosis of bacterial pneumonia with development of the Acute 
Respiratory Distress Syndrome. While evidencing understanding of the diagnosis and need for 
invasive ventilator support the spouse asked a further question: “When will the breathing machine 
not be needed anymore?” 
 The palliative medicine service representative on the intensive care unit rounding team was 
asked to speak further with the spouse regarding the prognosis and other outcome expectations. 
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Introduction 
 Acute lung injury (ALI) and its physiologically more severe subset, acute respiratory 
distress syndrome (ARDS), occur in a variety of clinical situations and identify patients at 
significant risk for mortality and other adverse outcomes.1  ALI and ARDS share a common 
pathophysiology.  An inflammatory process, whether occurring in the lung or elsewhere, incites a 
cytokine-mediated response which in the lung manifests as a loss of the integrity of the alveolar-
capillary interface, abnormal gas exchange, and adversely altered lung mechanics.  The clinical 
findings are acute hypoxemia and bilateral lung infiltrates on chest X-ray in the absence of 
congestive heart failure.  These characteristics form the basis for the definition and clinical 
diagnosis of ALI/ARDS.2 The severity of the hypoxemia indicated by the arterial oxygen level in 
mmHg to fraction of inspired oxygen ratio (PaO2/FiO2) distinguishes ALI from ARDS. In ALI the 
PaO2/FiO2 is less than 300 while a more severe gas exchange abnormality, PaO2/FiO2 of less 
than 200, leads to a diagnosis of ARDS.  All but the most fleeting cases will require ventilator 
support to allow management of the primary inciting event and hopefully resolution over time of 
the damage done to the lung by the inflammatory process.  Most often invasive ventilator support 
after tracheal intubation (ETMV) is required.3 
 Following the initial description of ARDS as a distinct clinical syndrome over 40 years 
ago,4 early reports described the short-term mortality as greater than 50%.1  The short-term 
mortality rate for ALI/ARDS is usually measured at the time of hospital discharge, intensive care 
unit (ICU) discharge, or at 28-30 days from the time of admission or diagnosis.  Enhanced 
understanding led to a consensus definition for ALI/ARDS in 1994 focusing efforts to characterize 
improved management strategies.2  A refinement of the definitions for ALI and ARDS not to 
mention a paradigm shift in management principles took place with an early publication of the 
ARDS Network (ARDSnet) of the National Heart, Lung, and Blood Institute in 2000.5  The short-
term mortality benefit of a lung-protective ventilator strategy as outlined in this publication was 
widely accepted and these principles applied over the subsequent years.6,7  While other 
interventions for severe cases, for example extracorporeal membrane oxygenation (ECMO) and 
high frequency oscillation (HFO),8 remain potentially useful and under investigation the ARDSnet 
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ventilation guidelines remain the only proven strategy with regards to ventilator management to 
reduce mortality.9,10  Advances in other aspects of critical care medicine have also benefited 
patients with ALI/ARDS over the last two decades.11,12 A  systematic review of studies up to 2006 
described a pooled mortality for ALI/ARDS of 43%.13  Similar pooled data are not available for 
long-term mortality or independence from ETMV as a separate outcome.  Increasing attention is 
being paid to the physical, neurocognitive, and psychological sequelae for ALI/ARDS survivors.14 
  The straightforward query asked by the spouse of the incapacitated intensive care unit 
(ICU) patient requiring tracheal intubation and mechanical ventilation (ETMV) for acute 
respiratory distress syndrome (ARDS) described in the case scenario triggers a complex set of 
considerations for the palliative care practitioner.  Questions that reflect the uncertainties faced by 
patients and families during a critical illness are ranked by them as among the most common and 
important:15,16 
  “Will he/she get better?” 
  “What are the chances that he/she recovers?” 
  When will he/she be able to breathe on his/her own?” 
  Will he/she have any aftereffects?” 
 Formulating responses to these questions and communicating them in an effective 
manner is an integral part of patient-centered communication and shared decision-making, the 
preferred models for interacting with families of incapacitated critically ill patients.17,18  Patient 
and family-centered communication requires that clinicians engage in a partnership with 
patients and/or their surrogates to develop care plans that are consistent with patients’ 
values and goals.  General communication techniques (e.g. empathic statements, active 
listening, attention to emotion, and eliciting questions) allow the medical provider to 
develop a shared understanding of the patient’s experiences with illness, decision-making 
preferences, prognostic awareness, and values and goals in the context of a life-limiting 
illness to better inform medical recommendations.19,20,21 
 Acknowledging and confronting the uncertainty inherent in a clinical situation such as that 
described in the case scenario is necessary for effective patient-centered communication to take 
ALI and ARDS in the Intensive Care Unit 7 
place.  Potential benefits are enhanced quality of the shared decision-making process as well as 
more effective immediate coping and reduced long-term residual emotional implications for the 
family members serving as surrogate decision-makers and informal caregivers.21,22  Addressing 
uncertainty as part of patient-centered communication requires the consideration of both short- 
and long-term outcomes.23  Increasingly recognized for the ALI/ARDS patient is the importance of 
incorporating into this discourse not only the mortality risk but also survivorship issues including a 
variety of potentially adverse effects on quality of life (QOL) for the survivor and their 
caregivers.24,25 
 This paper will provide information and recommendations necessary to formulate and 
express a response to the question posed by the surrogate decision maker and informal 
caregiver of the incapacitated ICU patient requiring ETMV for ARDS in the case scenario.  
Hopefully this presentation will also offer methods for dealing with uncertainty-generated 
questions in other scenarios, facilitating patient-centered communication, and optimizing shared 
decision-making.  A literature review providing current information regarding outcomes for ICU 
patients with ALI/ARDS requiring ETMV will be presented.  Specific recommendations for 
expressing this information in a way to optimally manage uncertainty as part of a patient-centered 
communication process will then be detailed. 
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Literature Review:  Outcome of Acute Lung Injury and Acute Respiratory Distress 
Syndrome requiring Tracheal Intubation and Mechanical Ventilation in the Intensive Care 
Unit 
 Studies reviewed are those reported in English from 2006 through 2010 providing 
absolute number data or survival/outcome graphs on mortality, both short- and long-term, as well 
as short- and long-term recovery of respiratory function (variously described as ventilator 
independence, breathing independently, breathing without assistance, or successful extubation) 
of adult patients receiving ETMV for ALI/ARDS in the ICU. 
Mortality and Recovery of Respiratory Function 
 An ARDSnet trial studied the potential mortality benefit of using corticosteroids in 
cases of ARDS of at least 7 days duration.26 30 day survival for the 180 patients enrolled in 
this trial was 77.2%.  Of these 139 survivors, 93 (66.9%) were extubated and independent 
of mechanical ventilation.  At 180 days there were 123 survivors (68.3%).  115 (93.5%) of 
these long-term survivors were breathing without assistance.  A separate ARDSnet 
investigation reported on the use of pulmonary-artery catheters to determine central 
venous pressure in patients with ALI.27  Among the 1000 patients in this trial 775 (77.5%) 
were alive and 660 (85.2% of survivors) extubated and free of mechanical ventilation at 30 
days.  There were 731 survivors (73.1%) at 60 days.  690 (94.4%) of these long-term 
survivors were independent of mechanical ventilation. 
 A smaller trial by Meduri et. al. also looked at the use of corticosteroids in ARDS, 
this time at an early stage.28  Among the 91 patients entered into this investigation, 70 
(76.9%) were alive and 57 (81.4% of survivors) breathing without assistance at 30 days.  
Follow-up at 1 year found 53 survivors (58.2%), all of whom were independent of 
mechanical ventilation.  
 A trial reported by the Lung Open Ventilation Study Investigators enrolled 983 
patients and evaluated ventilator management strategies for ALI/ARDS.29 There were 673 
survivors (68.5%) at 28 days with 417 of these survivors (62.0%) breathing independently.  
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At 75 days there were 496 survivors (50.5%).  417 of these survivors (84.1%) were 
breathing without assistance. 
 Finally, a recent study investigated the use of neuromuscular blockers in early 
ARDS.30 243 of 339 (71.7%) patients survived to 30 days.  189 (77.8%) of these short-term 
survivors were extubated and free of mechanical ventilation.  There were 213 survivors 
(62.8% of the initial cohort) at 90 days, all of whom were breathing independently. 
 In summary, short-term survival reported at 28-30 days in these trials for patients 
with ALI/ARDS requiring ETMV in the ICU ranged from 68.5-77.5%.  62.0-85.2% of these 
short-term survivors were extubated and independent of mechanical ventilation.  Long-
term follow-up in these studies was reported at intervals ranging from 60 days to 1 year. 
Long-term survival was 50-73% with greater than 84% of the survivors in each study 
breathing independently. 
Survivor Morbidity 
 Survivors of critical illness have been shown on long-term follow-up to have lower scores 
on scales correlating with quality of life (QOL) than age- and gender-matched members of the 
general population.31 ALI/ARDS survivors are at particular risk for an adverse impact on QOL.  
Physical factors can include pulmonary function impairment with exercise intolerance.32  
Neuromuscular dysfunction persists in many ALI/ARDS ICU survivors whether due to critical 
illness polyneuropathy, critical illness myopathy, or a combination of these disorders.14  
Neurocognitive aftereffects manifest as alterations of memory, attention, concentration, and 
executive function.33  Emotional disorders, most prominently anxiety, depression, and post-
traumatic stress disorder (PTSD) are recognized as aftereffects of an ICU course with 
ALI/ARDS.34  Informal caregivers of ALI/ARDS survivors are at risk for emotional distress and 
lifestyle alterations for an extended period of time.35 
The combined scores for mobility and energy as part of a QOL assessment for 38 ARDS 
survivors 6 months after hospital discharge were decreased compared to an age- and gender 
matched reference population.36 These were correlated with mild impairments in pulmonary 
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function tests, decreased performance on a 6 minute walk test, and persistent radiographic 
abnormalities. 
The Canadian Critical Care Trials Group identified a cohort of 109 ARDS survivors 
and reported on their functional outcomes in two sequential articles.37,38  At one year 
persistent functional limitations and impaired quality of life indices were attributed to 
muscle weakness and wasting.  49 % of these patients had returned to work.  5-year 
follow-up of 64 survivors documented improved but persistent impairment in exercise 
capability and quality of life as well as continued increased costs and use of health care 
services. 
ICU-acquired weakness or critical illness neuromyopathy occurs in nearly 50% of patients 
with sepsis who require mechanical ventilation for longer than 7 days and can persist up to 5 
years.32 Evidence of physical function deficits related to ICU-acquired neuromyopathy occurred in 
34.7% of ARDS survivors ventilated for 7 days or more.39 
Deficits in general intellectual functioning, processing speed, spatial skills, and executive 
function were cognitive effects noted in 67.6% of 74 ARDS survivors at hospital discharge.40 
These findings persisted in 39.2% of the patients at one year and 35.1% at two years post-
discharge. 
25 of 61 (41.0%) ARDS survivors reported moderate to severe symptoms of depression 
when interviewed 6-48 months after hospital discharge.41 51% of the group of 64 ALI/ARDS 
survivors reported by the Canadian Critical Care Trials Group had at least one episode of 
physician-diagnosed anxiety, depression, or both in the 5-year interval after hospital discharge.38 
In another report, 72.7% of 33 ARDS survivors reported multiple traumatic memories while 27.3% 
of this cohort was diagnosed with PTSD.42 
47 informal caregivers of ARDS survivors evaluated at 2 years post-discharge evidenced 
increased (compared to age- and gender-matched norms) emotional distress and alteration of 
lifestyle.35 These findings were more likely when evidence of emotional distress was also found in 
the survivor.  Family mental health problems were reported in 27% of the cases from the 
Canadian Critical Care Trials Group 5-year follow-up study.38 
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In summary, ALI/ARDS survivors are at risk for physical, neurocognitive, and 
psychological aftereffects for several months to years after the ICU experience.  Implications 
include an adverse impact on the ability to carry out activities of daily living, perform executive 
functions, demonstrate emotional well-being, and maintain employment status.       
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Managing Uncertainty 
 
The case scenario being addressed presents an example of an early phase of a critical 
illness.  A challenge for the palliative care practitioner working in an integrative or consultative 
relationship with intensive care colleagues is to establish an initial framework for patient-centered 
communication.19  Addressing and managing uncertainty with the patient’s family is a primary 
focus of this effort.    
The goal of the practitioner is to approach the management of uncertainty using a 
structure that fosters coping of the family while acknowledging that in terms of the delivery and 
content of these discussions “one size does not fit all”.43 Oftentimes practitioners feel compelled 
to reduce uncertainty.  However, uncertainty is neither inherently positive nor negative.  Some 
families will prefer to sustain uncertainty as a source of hope while others will experience 
uncertainty as anxiety-provoking.44   Moreover, practitioners habitually provide more information 
and education as the best strategy for managing uncertainty.  However, more information given to 
family members does not necessarily facilitate informed decision-making nor support coping.  In 
some cases, more information may be detrimental if the amount or type of information exceeds 
an individual’s ability to process it.45  It is paramount that communication regarding uncertainty 
includes a negotiation of what the individual perceives she needs to know in relation to her and to 
her loved one’s priorities.46   
When communicating about prognostic uncertainty, the delivery and content of 
information are of equal importance.  An accurate portrayal of the prognosis may help frame the 
uncertainties of the situation by openly acknowledging them and hopefully correcting 
preconceived notions that lead to excessively positive or negative expectations regarding 
outcome.  However, the “how and what” of prognostication that a practitioner presents again 
requires an individualized approach.  Some literature suggests that the presentation of statistical 
information as natural frequencies allows the formulation and expression of a prognostic 
assessment appropriate for the stage of the illness while other literature indicates that surrogates’ 
understanding or estimates of prognosis do not differ when conveyed numerically versus 
qualitiatively:47,48,49 
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 …..”is critically ill, this means there is uncertainty about what will happen.  If you take 
 100 people in this situation about 65 people would survive to leave the hospital.  Most of 
 these, ¾, would be breathing on their own.  Out of these 65 people who survive, about 
 another 10-15 will die during the next year.  Almost all of these longer term survivors will 
 be breathing on their own” (numerical)….. 
…..”there is a very real chance of survival but we cannot be certain about the 
 outcome” (qualitative)…..  
 Moreover, surrogate decision-makers desire a discussion that includes quality of life 
indicators in addition to survival estimates.50  Prognostic assessment should also include an 
introduction to outcomes other than mortality and, in this case scenario, ventilator independence:  
…..“we also know from experience that many people who have gone through this type of 
 serious illness will have effects on the life they are able to lead afterwards.  Physical 
 weakness and ongoing medical problems can continue for months or even years.  
 The trauma to a person of being this sick can cause emotional distress in the form of 
 depression or ongoing stress and anxiety.  This will also be emotionally stressful for you 
 both now and with the challenges that can happen in the future”….. 
 While individual preferences for the type and content of information must be considered, 
avoidance of a discussion of potential outcomes and their relative risks for fear of extinguishing 
hope is misguided.  The majority of physicians avoid discussing the prognosis when it is uncertain 
due to this fear.51,52,53  Most families desire prognostic information and are aware that irreducible 
uncertainty is present in clinical scenarios such as this.20  In fact, surrogate decision-makers’ 
estimate of prognosis is usually more optimistic than that of the physician and based on more 
variables than just the medical facts.47,54   Hope is a dynamic construct.  It is sought from sources 
other than the physician and is engendered differently by context, time and individual.46,52 
 A useful strategy for managing uncertainty is to contrast the hope and worry aspects of 
reacting to the clinical situation.  This dual agenda can be encouraged but not imposed as a 
framework for both understanding cognitively and coping emotionally with the inherent 
uncertainties already outlined.55,56  It can be used as a tool to promote prognostic awareness and 
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coping.  Uncertainty can be presented as a joint understanding between the care team and family 
creating the foundation for a relationship that will be supportive and foster shared decision-
making:    
 …..” We hope that a full recovery can happen…..however, we worry that surviving with 
 ongoing problems that affect his life – or dying – are no less real possibilities.  The 
 ICU team will use all of their medical knowledge and skill to help him and hope for a good 
 outcome while not knowing for sure whether it will work.  You have the worry of what will 
 happen to someone you care about so much, with no definite answers”….   
 Fostering a therapeutic relationship that leads to patient-centered communication is an 
essential component of acknowledging and addressing the emotional response to uncertainty.  
Emphasizing nonabandonment is recommended as an approach during these early 
discussions:57 
 …..”no matter what happens we will always do our best to make sure that he does 
 not suffer while we are trying to make him better…..will try to help you by 
 communicating on a regular basis; continuing to ask about the type and amount of 
 information you prefer to hear, and do our best to provide it….overall, we can promise to 
 keep you informed but cannot resolve the uncertainties we have talked about…..will be 
 here for you and call upon any resources we have available to help you cope with 
 balancing the hopes and worries”….. 
 Surrogate decision-makers may exhibit ambivalence or resistance to addressing the 
uncertainty inherent in their loved one’s clinical condition.  Techniques used in motivational 
interviewing may prove helpful in managing uncertainty in this context.  Resisting the “righting 
reflex” – the urge to address resistance by education or correcting perceptions – is a basic 
principle of this strategy.58 Instead, motivational interviewing encourages exploration of an 
individual’s motivations that are driving the resistance. Tools such as reflective and summative 
statements convey empathy, emphasize listening, and explore values and emotions that can lead 
to resolution of ambivalence and foster shared decision-making: 
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 …..”it seems you have a good understanding of how serious the situation is but also 
 frightened about what might happen and how long this might take. Do I have it right?”..... 
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Conclusion 
 Outcome predictions for a person with ALI/ARDS requiring ETMV in the ICU are fraught 
with uncertainty.  While the application of current principles for management and therapeutics 
offers a realistic hope for recovery of respiratory function and premorbid functional status, death 
or survival with significant aftereffects also occur in similar proportions.   Acknowledging this 
uncertainty, in our scenario with the representative of an incapacitated person, is an integral 
component of patient-centered communication.  Managing uncertainty involves addressing the 
cognitive and affective aspects of the response to the indefinite outcome expectations generated 
by a situation such as this.  
 There are limitations to the application of the literature review reported here to 
formulating a prognostic assessment.  The studies analyzed present data from heterogeneous 
groups of patients with various precipitating events leading to ALI/ARDS and receiving different 
interventions.  The studies in the literature review report data from the experimental and control 
groups in investigations of issues related to different techniques and technologies with regards to 
the application of ETMV for patients with ALI/ARDS. These issues are of great importance in 
promoting the best possible outcomes for ALI/ARDS patients receiving ETMV. The literature 
review used in this report allows the accumulation of a sizeable sample and a statement of a 
general outcome trend with some confidence but limits the ability to accurately predict outcome 
for an individual patient.   
 Analyzing the outcome possibilities for an incapacitated person with ALI/ARDS requiring 
ETMV in an ICU and addressing the uncertainties inherent in them with family is an example of 
patient-centered communication that has the potential to alleviate short- and long-term distress 
and improve the quality of a shared-decision making process. Managing uncertainty begins with 
skillfully expressing a carefully formulated prognostic assessment that includes the outcomes of 
highest probability and greatest importance with regards to survival and quality of life. Although 
there are no clear best practices for discussing uncertainty, uncertainty is inherent in the 
experience of families with loved ones’ in the ICU.  Communicating uncertainty does not 
extinguish hope for most families.  A discussion of uncertainty needs to be tailored to the needs 
ALI and ARDS in the Intensive Care Unit 17 
of the individual family.  Applying motivational interviewing skills and the “hope and worry” 
technique will aid in supporting family members as they cope with uncertainty and decision-
making for their loved one.  
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